Upgrade to SI Premium - Free Trial

Oppenheimer Assumes Aquestive Therapeutics (AQST) at Outperform

April 24, 2026 6:14 AM
Oppenheimer analyst Mazahir Alimohamed assumes coverage on Aquestive Therapeutics (NASDAQ: AQST) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

New Coverage